We observed that several genes including PTCH1, ATXN1, DLL4, SOX2 and DACH1 were differentially regulated in tbLCM-treated breast cancer cells as compared to those treated with tnLCM or BM control (Fig. 3D). The gene discussed is SOX2; the disease is breast carcinoma.